Europe — EMA
Efluelda
Efluelda is a quadrivalent influenza vaccine designed to protect against influenza viruses. It is administered intramuscularly or subcutaneously and is suitable
Request sourcing
What is B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type), Influenza Virus B/Michigan/01/2021, I?
Efluelda is a quadrivalent influenza vaccine designed to protect against influenza viruses. It is administered intramuscularly or subcutaneously and is suitable for individuals seeking seasonal flu protection.
What is B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type), Influenza Virus B/Michigan/01/2021, I used for?
Efluelda is used to prevent influenza caused by specific strains of the virus. This vaccine is typically administered annually to help reduce the risk of flu infection and its complications. It is particularly relevant for those looking to safeguard against seasonal influenza.
What are the side effects of B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type), Influenza Virus B/Michigan/01/2021, I?
Common effects of Efluelda may include mild soreness or redness at the injection site. Some individuals might experience temporary discomfort, fatigue, or low-grade fever following vaccination. These effects are generally mild and short-lived.
What precautions apply to B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type), Influenza Virus B/Michigan/01/2021, I?
Efluelda should be administered by healthcare professionals. Individuals with a history of severe allergic reactions to previous influenza vaccines or any of its components should consult a healthcare provider before use. Always follow the guidance of a medical professional regarding vaccination.
What does B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type), Influenza Virus B/Michigan/01/2021, I interact with?
Efluelda may interact with certain medications or health conditions. It is important to inform your healthcare provider about any ongoing treatments or health issues before receiving the vaccine. Specific interactions should be discussed with a medical professional.